Guerbet (XPAR:GBT) Moat Score: 0/10 (As of Jul. 03, 2026)


XPAR:GBT Guerbet SA XPAR:GBT
62 GF Score
Price €8.92
GF Value €19.62
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Guerbet Moat Score?

Guerbet has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Guerbet has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Guerbet might have No Moat - No discernible moat.

Guerbet  (XPAR:GBT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Guerbet Moat Score Related Terms

XPAR:GBT
62GF Score
Guerbet SA XPAR:GBT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guerbet (XPAR:GBT) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of €8.92 is trading 54.5% below its estimated GF Value™ of €19.62. GuruFocus considers Guerbet to be Possible Value Trap.

Key valuation signals for XPAR:GBT:

  • Moat Score: 0
  • GF Value™: €19.62 vs. price of €8.92 (54.5% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the XPAR:GBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guerbet Business Description

Other Exchanges 0ELV:UK4G8:Germany
Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
62GF Score

Get the complete analysis for XPAR:GBT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.92
Price
€19.62
GF Value